SCHEMBL3209142

SCHEMBL3209142

COc1cc(NC(=O)OCC2c3ccccc3-c3ccccc32)c(C(=O)O)cc1OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.53
ALDH1A1 P00352 2/20 0.53
HPGD P15428 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
HSD17B10 Q99714 1/20 0.53
RCE1 Q9Y256 1/20 0.53
KMT2A Q03164 6/20 0.52
MEN1 O00255 4/20 0.52
GFER P55789 1/20 0.52
EPHX2 P34913 1/20 0.52
TP53 P04637 1/20 0.51
MAPT P10636 3/20 0.49
FABP5 Q01469 1/20 0.49
TSHR P16473 1/20 0.48
GAA P10253 1/20 0.47
MAPK1 P28482 1/20 0.47
AKR1C4 P17516 1/20 0.46
AKR1C3 P42330 1/20 0.46
AKR1C2 P52895 1/20 0.46
AKR1C1 Q04828 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6345026 0.85 EPHX2 (0.54) KDM4EALDH1A1HPGDKMT2AMEN1
SCHEMBL1157417 0.85 EPHX2 (0.55) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL3206099 0.84 EPHX2 (0.52) KMT2AEPHX2FABP5CA12CA1
SCHEMBL3199951 0.84 EPHX2 (0.57) ALDH1A1KMT2AMEN1GFEREPHX2
SCHEMBL569486 0.83 EPHX2 (0.60) ALDH1A1NPSR1KMT2AEPHX2FABP5
SCHEMBL7927995 0.83 LTB4R (0.52) KMT2AMEN1EPHX2FABP5GAA
SCHEMBL3203815 0.82 EPHX2 (0.65) KDM4EALDH1A1HSD17B10KMT2AMEN1
SCHEMBL3220027 0.82 EPHX2 (0.55) KMT2AEPHX2FABP5
SCHEMBL6346117 0.82 EPHX2 (0.52) KMT2AEPHX2FABP5
SCHEMBL119223 0.82 EPHX2 (0.60) KDM4EKMT2AMEN1EPHX2FABP5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682123-B2 Methods of treating metabolic disease THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2017-06-20 US disclosed
US-20150190466-A1 METHODS OF TREATING METABOLIC DISEASE NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2015-07-09 US disclosed
US-20130160150-A1 METHODS FOR IDENTIFYING COMPOUNDS THAT MODULATE LISCH-LIKE PROTEIN OR C1ORF32 PROTEIN ACTIVITY AND METHODS OF USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2013-06-20 US disclosed
US-8460880-B2 Compositions, splice variants and methods relating to ovarian specific genes and proteins DIADEXUS, INC. (US) 2013-06-11 US disclosed
US-7678889-B2 Compositions and methods relating to ovarian specific genes and proteins DIADEXUS, INC. (US) 2010-03-16 US disclosed
US-20090263411-A1 Compositions, splice variants and methods relating to ovarian specific genes and proteins DIAZYME LABORATORIES, INC. 2009-10-22 US disclosed
WO-2009076651-A9 METHODS FOR IDENTIFYING COMPOUNDS THAT MODULATE LISCH-LIKE PROTEIN OR C1ORF32 PROTEIN ACTIVITY AND METHODS OF USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2009-08-27 WO disclosed
WO-2009076651-A2 METHODS FOR IDENTIFYING COMPOUNDS THAT MODULATE LISCH-LIKE PROTEIN OR C1ORF32 PROTEIN ACTIVITY AND METHODS OF USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2009-06-18 WO disclosed
US-20090118175-A1 Compositions and Methods for Detection, Prognosis and Treatment of Breast Cancer MACINA ROBERTO A 2009-05-07 US disclosed
US-20080260761-A1 Compositions, Splice Variants and Methods Relating to Cancer Specific Genes and Proteins DIADEXUS, INC. 2008-10-23 US disclosed
WO-2002039431-A2 COMPOSITIONS AND METHODS RELATING TO PROSTATE SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2002-05-16 WO disclosed
WO-2002036616-A2 COMPOSITIONS AND METHODS RELATING TO BREAST SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2002-05-10 WO disclosed
WO-2002036807-A2 COMPOSITIONS AND METHODS RELATING TO BREAST SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2002-05-10 WO disclosed
WO-2002036808-A2 COMPOSITIONS AND METHODS RELATING TO PROSTATE SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2002-05-10 WO disclosed
US-20020048763-A1 Human genome-derived single exon nucleic acid probes useful for gene expression analysis AMERSHAM PLC (GB) 2002-04-25 US disclosed
US-20020048800-A1 Myosin-like gene expressed in human heart and muscle GE HEALTHCARE LIMITED (GB) 2002-04-25 US disclosed
WO-2002026818-A2 HUMAN NEDD-1 AEOMICA, INT. (US) 2002-04-04 WO disclosed
WO-2002024718-A1 COMPOSITIONS AND METHODS RELATING TO PROSTATE SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2002-03-28 WO disclosed
WO-2002024750-A2 HUMAN KIDNEY TUMOR OVEREXPRESSED MEMBRANE PROTEIN 1 AEOMICA, INC. (US) 2002-03-28 WO disclosed
WO-2001092524-A2 MYOSIN-LIKE GENE EXPRESSED IN HUMAN HEART AND MUSCLE AEOMICA, INC. (US) 2001-12-06 WO disclosed